Conference
A phase I study of BI 853520, an inhibitor of focal adhesion kinase (FAK), in patients with advanced or metastatic solid tumors.
Authors
Zer A; Verheijen R; De Vos FYFL; Hotte S; Eskens F; Pronk L; Siu LL; Schnell D; Steeghs N; Langenberg MH
Volume
33
Pagination
pp. 2541-2541
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2015
DOI
10.1200/jco.2015.33.15_suppl.2541
Conference proceedings
Journal of Clinical Oncology
Issue
15_suppl
ISSN
0732-183X